AnaptysBio Inc
(NAS:ANAB)
$
23.94
-0.67 (-2.72%)
Market Cap: 654.01 Mil
Enterprise Value: 335.04 Mil
PE Ratio: 0
PB Ratio: 13.68
GF Score: 62/100 AnaptysBio Inc (ANAB) Transcripts
- AnaptysBio Inc to Provide Overview of Rosnilimab, a PD-1 Agonist, at Virtual R&D Event TranscriptOct 25, 2023
- AnaptysBio Inc To virtual BTLA Agonist (ANB032) R&D Event TranscriptMay 25, 2023
- AnaptysBio Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2022
- AnaptysBio Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- AnaptysBio Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 17, 2020
- AnaptysBio Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- AnaptysBio Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- 1